Thienopyrimidinediones and their use in the modulation of autoimmune disease
Details for Australian Patent Application No. 2002319469 (hide)
International Classifications
Event Publications
16 January 2003 Complete Application Filed
Priority application(s): 0118479.5 28.07.01 GB
29 May 2003 Application Open to Public Inspection
Published as AU-B-2002319469
9 August 2007 Application Accepted
Published as AU-B-2002319469
6 September 2007 Corrigenda
Applications Accepted - Name Index Under the name AstraZeneca AB, Application No. 2002319469, under INID (72), correct the name of the co-inventor to read Rasul, Rukhsana, Tasneem
6 December 2007 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002319470-LEVEL AND DENSITY MEASUREMENT USING GAMMA RADIATION
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser